CMS launches the Medicare GLP-1 Bridge — but 4 questions linger
(By: Elizabeth Casolo for Becker’s Hospital Review) CMS is rolling out the Medicare GLP-1 Bridge program — a demonstration designed
Read More
GLP-1 drugs
Primary care doctors raise alarm as telehealth companies get involved in obesity drugs
(By Sydney Lupkin for NPR) Every time David Davis talks to a nurse at Vida Health, he thinks he’ll finally
Read More
GLP-1s in Medicare and Medicaid: Access alone is not a care model
(Pankhuri Sharma, Humana for Becker’s Hospital Review) The clinical value of GLP-1 receptor agonists is now well established. Multiple trials
Read MoreWhat to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge
(Authors: Meredith Freed, Juliette Cubanski, and Elizabeth Williams for The Kaiser Family Foundation Published: May 11, 2026) GLP-1s, a class
Read MoreA New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
(By Jackie Fortiér for KFF Health News) Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription
Read MoreWhat Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
(By Juliette Cubanski for The Kaiser Family Foundation published March 9, 2026) The Centers for Medicare & Medicaid Services (CMS)
Read MorePoll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford
(Contact – Craig Palosky for The Kaiser Family Foundation published November 14, 2025) About one in eight adults (12%) say
Read MoreWegovy gains new approval: 3 GLP-1 updates
(By: Paige Twenter for Becker’s Hospital Review) Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1
Read MoreMedicare will not cover GLP-1s for weight loss: 3 notes
(By: Erica Carbajal for Becker’s Hospital Review) CMS said April 4 it will not move forward with a Biden-era proposal
Read MoreFDA approves GLP-1 generic
(By Paige Twenter for Becker’s Hospital Review) On Dec. 23, the FDA approved Hikma Pharmaceuticals’ liraglutide injection, a generic version
Read More